Phase 1 Clinical Trials
Clinilabs Drug Development Corporation provides full range of CNS Phase I capabilities, with extensive experience in early phase studies required for regulatory approval. We offer expertise that provides a sound foundation for all Phase I projects.
First in human
First in class
Single ascending dose (SAD)
Multiple ascending dose (MAD)
Bioequivalence (BE)
Drug – drug interaction studies
Drug – alcohol interactions studies
Food effect studies
Pharmacokinetic (PK) studies
Pharmacodynamic (PD) studies
Kinetic-dynamic relationships
Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.
– George W. Merck